HROP68: A rare case of medullary pancreatic cancer-characterization and chemosensitivity of the first patient-derived cell line.

MLA

von den Driesch, Jens, et al. “HROP68: A Rare Case of Medullary Pancreatic Cancer-Characterization and Chemosensitivity of the First Patient-Derived Cell Line.” Frontiers in Oncology, vol. 12, Jan. 2023, p. 1082927. EBSCOhost, https://doi.org/10.3389/fonc.2022.1082927.

APA

von den Driesch, J., Flöttmann, J., Prall, F., Mullins, C. S., Linnebacher, M., & Bürtin, F. (2023). HROP68: A rare case of medullary pancreatic cancer-characterization and chemosensitivity of the first patient-derived cell line. Frontiers in Oncology, 12, 1082927. https://doi.org/10.3389/fonc.2022.1082927

Chicago

von den Driesch, Jens, Jana Flöttmann, Friedrich Prall, Christina S Mullins, Michael Linnebacher, and Florian Bürtin. 2023. “HROP68: A Rare Case of Medullary Pancreatic Cancer-Characterization and Chemosensitivity of the First Patient-Derived Cell Line.” Frontiers in Oncology 12 (January): 1082927. doi:10.3389/fonc.2022.1082927.